EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Immunogenicity, Safety, and Protective Efficacy of Mucosal Vaccines Against Respiratory Infectious Diseases: A Systematic Review and Meta-Analysis

Jiaqi Chen iD, Weitong Lin, Chaokai Yang, Wenqi Lin, Xinghui Cheng, Haoyuan He, Xinhua Li, Jingyou Yu iD

Vaccines · 31.07.2025 · 13 (8) · 825

DOI: 10.3390/vaccines13080825 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 31.07.2025. Verfasst von Jiaqi Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nanshan School, Guangzhou Medical University, Guangzhou 510180, China. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major Project of Guangzhou National Laboratory, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Mucosal vaccines, delivered intranasally or via inhalation, are being studied for respiratory infectious diseases like COVID-19 and influenza. These vaccines aim to provide non-invasive administration and strong immune responses at infection sites, making them a promising area of research. This systematic review and meta-analysis assessed their immunogenicity, safety, and protective efficacy.

Methods

The study design was a systematic review and meta-analysis, searching PubMed and Cochrane databases up to 30 May 2025. Inclusion criteria followed the PICOS framework, focusing on mucosal vaccines for COVID-19, influenza, RSV, pertussis, and tuberculosis.

Results

A total of 65 studies with 229,614 participants were included in the final analysis. Mucosal COVID-19 vaccines elicited higher neutralizing antibodies compared to intramuscular vaccines (SMD = 2.48, 95% CI: 2.17–2.78 for wild-type; SMD = 1.95, 95% CI: 1.32–2.58 for Omicron), with varying efficacy by route (inhaled VE = 47%, 95% CI: 22–74%; intranasal vaccine VE = 17%, 95% CI: 0–31%). Mucosal influenza vaccines protected children well (VE = 62%, 95% CI: 30–46%, I2 = 17.1%), but seroconversion rates were lower than those of intramuscular vaccines. RSV and pertussis vaccines had high seroconversion rates (73% and 52%, respectively). Tuberculosis vaccines were reviewed systemically, exhibiting robust cellular immunogenicity. Safety was comparable to intramuscular vaccines or placebo, with no publication bias detected.

Conclusions

Current evidence suggests mucosal vaccines are immunogenic, safe, and protective, particularly for respiratory diseases. This review provides insights for future research and vaccination strategies, though limitations include varying efficacy by route and study heterogeneity.

Schlagwörter

Stichwörter der Autor:innen

immunogenicitymeta-analysismucosal vaccinerespiratory infectious diseasessafetyvaccine efficacy

Autor:innen und Institutionen

  • Nanshan School, Guangzhou Medical University, Guangzhou 510180, China.
  • Guangzhou National Laboratory, Bio-Island, Guangzhou 510005, China.
  • The Third School of Clinical Medicine, Guangzhou Medical University, Guangzhou 510180, China.
  • The Second School of Clinical Medicine, Guangzhou Medical University, Guangzhou 510180, China.
  • State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510182, China.

ORCID-Profile: Jiaqi Chen, Jingyou Yu

Förderung

  • Major Project of Guangzhou National Laboratory
  • National Natural Science Foundation of China

Zitieren

APA

Chen, J., Lin, W., Yang, C., Lin, W., Cheng, X., He, H., Li, X., & Yu, J. (2025). Immunogenicity, Safety, and Protective Efficacy of Mucosal Vaccines Against Respiratory Infectious Diseases: A Systematic Review and Meta-Analysis. Vaccines, 13(8), 825. https://doi.org/10.3390/vaccines13080825

Vancouver

Chen J, Lin W, Yang C, Lin W, Cheng X, He H, et al. Immunogenicity, Safety, and Protective Efficacy of Mucosal Vaccines Against Respiratory Infectious Diseases: A Systematic Review and Meta-Analysis. Vaccines. 2025;13(8):825. doi:10.3390/vaccines13080825

BibTeX
@article{Chen2025,
  author = {Chen, Jiaqi and Lin, Weitong and Yang, Chaokai and Lin, Wenqi and Cheng, Xinghui and He, Haoyuan and Li, Xinhua and Yu, Jingyou},
  title = {Immunogenicity, Safety, and Protective Efficacy of Mucosal Vaccines Against Respiratory Infectious Diseases: A Systematic Review and Meta-Analysis},
  journal = {Vaccines},
  year = {2025},
  volume = {13},
  number = {8},
  pages = {825},
  doi = {10.3390/vaccines13080825}
}
Kostenlos starten →